We are live on ! Find out more
ELOS

Syneron Medical Ltd
ELOS

Delisted

ELOS was delisted on the 14th of July, 2017.

68 hedge funds and large institutions have $252M invested in Syneron Medical Ltd in 2014 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

27% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 15

5% more funds holding

Funds holding: 6568 (+3)

7% less capital invested

Capital invested by funds: $270M → $252M (-$18M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
68
Holders Change
+3
Holders Change %
+4.62%
% of All Funds
1.81%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
14
Increased
19
Reduced
15
Closed
10
Calls
$37K
Puts
Net Calls
+$37K
Net Calls Change
-$644K
Name Holding Trade Value Shares
Change
Change in
Stake
Victory Capital Management
26
Victory Capital Management
Texas
$1.22M
California Public Employees Retirement System
27
California Public Employees Retirement System
California
$954K +$508K +52,700 +152%
TA
28
Teton Advisors
New York
$945K
PIM
29
Profit Investment Management
Maryland
$907K -$71.6K -7,422 -7%
DC
30
Davenport & Co
Virginia
$875K -$230K -23,810 -20%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$873K +$290K +30,097 +47%
DCM
32
DAFNA Capital Management
California
$849K
Bank of New York Mellon
33
Bank of New York Mellon
New York
$801K +$98.7K +10,233 +14%
Two Sigma Investments
34
Two Sigma Investments
New York
$737K +$121K +12,516 +19%
Citadel Advisors
35
Citadel Advisors
Florida
$532K +$549K +56,957 New
Two Sigma Advisers
36
Two Sigma Advisers
New York
$524K -$14.5K -1,500 -3%
MC
37
Moors & Cabot
Massachusetts
$416K -$9.64K -1,000 -2%
NCCM
38
Nine Chapters Capital Management
New Jersey
$236K +$244K +25,300 New
GI
39
GAMCO Investors
Connecticut
$224K
NCMW
40
Northern Capital Management (Wisconsin)
Wisconsin
$211K +$16.9K +1,750 +8%
KeyBank National Association
41
KeyBank National Association
Ohio
$206K +$213K +22,065 New
Morgan Stanley
42
Morgan Stanley
New York
$195K +$88.5K +9,181 +78%
BG
43
BlackRock Group
United Kingdom
$154K
Invesco
44
Invesco
Georgia
$152K +$8.04K +834 +5%
IAM
45
Iridian Asset Management
Connecticut
$135K -$63.8K -6,620 -31%
GF
46
Gabelli Funds
New York
$131K
Nomura Holdings
47
Nomura Holdings
Japan
$114K -$461K -47,809 -80%
State Street
48
State Street
Massachusetts
$109K
ARTA
49
A.R.T. Advisors
New York
$103K +$107K +11,113 New
Geode Capital Management
50
Geode Capital Management
Massachusetts
$102K +$106K +11,033 New

ELOS Hedge Fund Activity: Q4 2014 in Review

68 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Syneron Medical Ltd (ELOS) for Q4 2014, worth a combined $252M — down 6.7% from $270M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new ELOS positions and 10 closed out — a net gain of 4 holders — while 19 added to existing stakes and 15 trimmed.

The largest buyer was Senzar Asset Management, opening a new position worth an estimated $2.9M. The largest seller was Baupost Group, cutting an estimated $5.58M.

  • 68 institutional investors held Syneron Medical Ltd (ELOS) as of Q4 2014, up from 65 in Q3 2014.
  • Funds reported $252M of Syneron Medical Ltd stock for Q4 2014, down 6.7% quarter-over-quarter.
  • 14 funds opened new Syneron Medical Ltd positions in Q4 2014 and 10 closed out, a net change of +4 holders.
  • The largest Syneron Medical Ltd buyer in Q4 2014 was Senzar Asset Management, an estimated $2.9M added.
  • The largest Syneron Medical Ltd seller in Q4 2014 was Baupost Group, an estimated $5.58M sold.

Based on aggregated 13F filings for Q4 2014.